Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
Search
:::

林裕誠 (Yu-Cheng Lin)

林裕誠(Yu-Cheng Lin)圖 Appointment

[Profile]

  • Education
    • Bachelor of Medicine, College of Medicine; National Taiwan University ,
    • Doctor of Medicine, Graduate Institute of Clinical Medicine; National Taiwan University,
  • Career and Experience
    Current Positions：
    • - Now, Attending physician, Department of Pediatrics, Taipei Veterans General Hospital,
    • - Now, Chief, Pediatric Gastroenterology, Taipei Veterans General Hospital,
    • - Now, Board Member, Taiwan Society of Pediatric Gastroenterology, Hepatology, and Nutrition,
    • - Now, Board Member, Chinese Taipei Society for the Study of Obesity,
    • - Now, Director, Taiwan Children Liver Foundation,
    • - Now, Scientific Committee Member, Asia Pan-Pacific Society for Pediatric Gastroenterology, Hepatology, and Nutrition,
    • - Now, Committee Member, Research Committee, Taiwan Pediatric Association,
    • - Now, Committee Member, Pediatric Gastroenterology Committee, Taiwan Pediatric Association,
    Experiences：
    • - , Attending Physician, Department of Pediatrics, Far Eastern Memorial Hospital,
    • - , Director, Department of Medical Affairs, Far Eastern Memorial Hospital,
    • - , Director, Pediatric Emergency Department, Far Eastern Memorial Hospital,
    • - , Director, Core Laboratory, Far Eastern Memorial Hospital,
    • - , Reviewer, Department of Life Sciences, National Science and Technology Council,
  • Medical Expertise
    1. Pediatric and Adolescent Obesity, Fatty Liver
    2. Growth Delay in Infants, Nutritional Counseling for Infants and Young Children
    3. Pediatric and Adolescent Gastrointestinal Diseases: Vomiting, Diarrhea, Abdominal Pain, Constipation, GI Bleeding, etc.
    4. Prevention and Treatment of Pediatric and Adolescent Liver and Gallbladder Diseases
    5. Abdominal Ultrasound, Gastroduodenoscopy, Colonoscopy, Fibroscan
  • License
    Pediatrician Pediatric Gastroenterologist Obesity Specialist Adolescent Medicine Specialist Gastrointestinal Endoscopy Specialist

[Publications]

  1. Yu-Cheng Lin, Chang PF, Hu FC, Chang MH, Ni YH. Variants in the UGT1A1 gene and the risk of pediatric non-alcoholic fatty liver disease. Pediatrics. 2009:124(6):e1221-7.
  2. Yu-Cheng Lin, Chang PF, Yeh SJ, Liu K, Chen HC. Risk factors associated with liver steatosis in obese children and adolescents. Pediatrics and Neonatology. 2010;51(3):149−54.
  3. Yu-Cheng Lin, Chang PF, Hu FC, Yang WS, Chang MH, Ni YH. A common variant in the PNPLA3 gene is a risk factor for nonalcoholic fatty liver disease in obese Taiwanese children. Journal of Pediatrics. 2011;158(5):740-4.
  4. Yu-Cheng Lin, Chang PF, Chang MH, Ni YH. A common variant in the peroxisome proliferator-activated receptor-γ coactivator-1α gene is associated with nonalcoholic fatty liver disease in obese children. American Journal of Clinical Nutrition. 2013;97(2):326-31.
  5. Yu-Cheng Lin, Chang PF, Chang MH, Ni YH. Genetic variants in GCKR and PNPLA3 confer susceptibility to nonalcoholic fatty liver disease in obese individuals. American Journal of Clinical Nutrition. 2014;99(4):869-74.
  6. Chang PF, Yu-Cheng Lin, Liu K, Yeh SJ, Ni YH. Heme oxygenase-1 gene promoter polymorphism and the risk of pediatric nonalcoholic fatty liver disease. International Journal of Obesity. 2015;39(8):1236-40.
  7. Yu-Cheng Lin, Chang PF, Lin HF, Liu K, Chang MH, and Ni YH. Variants in the autophagy related gene IRGM confer susceptibility to nonalcoholic fatty liver disease by modulating lipophagy. Journal of Hepatology. 2016;65(6):1209-1216.
  8. Yu-Cheng Lin, Ni YH. Reply to: “Title: The IRGM rs10065172 variant increases the risk for steatosis but not for liver damage progression in Italian obese children”. Journal of Hepatology. 2017;67(3):655-656.
  9. Wong VW, Chan WK, Chitturi S, Chawla Y, Dan YY, Duseja A, Fan J, Goh KL, Hamaguchi M, Hashimoto E, Kim SU, Lesmana LA, Yu-Cheng Lin, Liu CJ, Ni YH, Sollano J, Wong SK, Wong GL, Chan HL, Farrell G. The Asia-Pacific Working Party on Nonalcoholic Fatty Liver Disease Guidelines 2017 Part 1: Definition, risk factors and assessment. Journal of Gastroenterology and Hepatology. 2018;33(1):70-85.
  10. Chitturi S, Wong VW, Chan WK, Wong GL, Wong SK, Sollano J, Ni YH, Liu CJ, Yu-Cheng Lin, Lesmana LA, Kim SU, Hashimoto E, Hamaguchi M, Goh KL, Fan J, Duseja A, Dan YY, Chawla Y, Farrell G, Chan HL. The Asia-Pacific Working Party on Nonalcoholic Fatty Liver Disease Guidelines 2017 Part 2: Management and special groups. Journal of Gastroenterology and Hepatology. 2018;33(1):86-98.
  11. Yu-Cheng Lin, Pi-Feng Chang, Mei-Hwei Chang and Yen-Hsuan Ni. Genetic determinants of hepatic steatosis and serum cytokeratin-18 fragment levels in Taiwanese children. Liver International. 2018;38(7):1300-1307.
  12. Hong-Hsing Liu, Yu-Cheng Lin, Chen-Shuan Chung, Kevin Liu, Ya-Hui Chang, Chung-Hsiang Yang, Yun Chen, Yen-Hsuan Ni and Pi-Feng Chang*. Integrated counts of carbohydrate-active protein domains as metabolic readouts to distinguish probiotic biology and human fecal metagenomes. Scientific Reports. 2019;9(1):16836.
  13. May-Jen Huang, Yu-Cheng Lin, Kevin Liu, Pi-Feng Chang, Ching-Shan Huang. Effects of variation status and enzyme activity for UDP-glucuronosyltransferase 1A1 gene on neonatal hyperbilirubinemia. Pediatrics and Neonatology. 2020;61(5):506-512.
  14. Yu-Cheng Lin, CC Wu, YH Ni. New Perspectives on Genetic prediction for pediatric metabolic associated fatty liver disease. Frontiers in Pediatrics. 2020;8:603654.
  15. Yu-Cheng Lin, PF Chang, K Liu, MH Chang and YH Ni. Predictors for incidence and remission of nonalcoholic fatty liver disease in obese children and adolescents. Journal of the Formosan Medical Association. 2022;121:36-42.
  16. Yu-Cheng Lin, Lin HF, Wu CC, Chen CL, Ni YH. Pathogenic effects of Desulfovibrio in the gut on fatty liver in diet-induced obese mice and children with obesity. Journal of Gastroenterology. 2022;57:913-925.
  17. Chen CL, Yu-Cheng Lin. Autophagy dysregulation in metabolic associated fatty liver disease: a new therapeutic target. International Journal of Molecular Sciences. 2022;23(17):10055.
  18. Yu-Cheng Lin, Chang PF, Ni YH. Updated upper limits of normal serum alanine aminotransferase levels for screening metabolic dysfunction-associated fatty liver disease in obese children. Journal of the Formosan Medical Association. 2022,121, 2548-2555.
  19. Pei-Ching Liu, Yu-Cheng Lin, Bih-Shya Gau, Heng-Hsin Tung, Sophia H. Hu, Chi-Wen Chen. Association between lifestyle-related, psychosocial factors and obesity among female adolescents in Taiwan. Journal of Pediatric Nursing. 2023;68:e58-e68.
  20. Po-Sheng Chang, Pi-Feng Chang, Yu-Cheng Lin. Usefulness of the triglyceride glucose index to predict nonalcoholic fatty liver disease in children with obesity. Journal of Pediatrics. 2023;255:260-261.       
回到最上